Cite
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
MLA
Schrijver, Lh, et al. Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315717693&authtype=sso&custid=ns315887.
APA
Schrijver, L., Olsson, H., Phillips, K.-A., Terry, M., Goldgar, D., Kast, K., Engel, C., Mooij, T., Adlard, J., Barrowdale, D., Davidson, R., Eeles, R., Ellis, S., Evans, D., Frost, D., Izatt, L., Porteous, M., Side, L., Walker, L., … Overbeek, L. (2018). Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.
Chicago
Schrijver, Lh, H Olsson, K-A Phillips, Mb Terry, De Goldgar, K Kast, C Engel, et al. 2018. “Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315717693&authtype=sso&custid=ns315887.